GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Invitro International (OTCPK:IVRO) » Definitions » Change In Payables And Accrued Expense

Invitro International (Invitro International) Change In Payables And Accrued Expense : $0.00 Mil (TTM As of Jun. 2097)


View and export this data going back to 1991. Start your Free Trial

What is Invitro International Change In Payables And Accrued Expense?

Invitro International's Change In Payables And Accrued Expense for the quarter that ended in Jun. 2097 was $0.00 Mil. It means Invitro International's Accounts Payable & Accrued Expense stayed the same from Mar. 2097 to Jun. 2097 .

Invitro International's Change In Payables And Accrued Expense for the fiscal year that ended in Sep. 2096 was $0.00 Mil. It means Invitro International's Accounts Payable & Accrued Expense stayed the same from Sep. 2095 to Sep. 2096 .

Invitro International Change In Payables And Accrued Expense Historical Data

The historical data trend for Invitro International's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invitro International Change In Payables And Accrued Expense Chart

Invitro International Annual Data
Trend Feb90 Feb91 Sep92 Sep93 Sep94 Sep95 Sep96
Change In Payables And Accrued Expense
Get a 7-Day Free Trial 0.70 -0.30 0.10 -0.50 -

Invitro International Quarterly Data
Sep92 Dec92 Mar93 Jun93 Sep93 Dec93 Mar94 Jun94 Sep94 Dec94 Mar95 Jun95 Sep95 Dec95 Mar96 Jun96 Sep96 Dec96 Mar97 Jun97
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Invitro International Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Jun. 2097 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Invitro International Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Invitro International's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Invitro International (Invitro International) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Invitro International (OTCPK:IVRO) » Definitions » Change In Payables And Accrued Expense
Comparable Companies
ASX:LSH IDTA TSXV:TELO ASX:CTE XSAT:ALPH BOM:526301 ABMC BOM:541299 BOM:526546 NGM:LIFE B XLRM TSXV:AVCR TEAR WAR:BMX XKRX:271850 TSXV:MBI.H WAR:IGN BOM:526504 BOM:516110 SGX:505
Traded in Other Exchanges
N/A
Address
330 East Orangethorpe Avenue, Suite D, Placentia, CA, USA, 92870
Website
https://www.invitrointl.com
Invitro International is a provider of non-animal testing methods. The company develops and commercializes test kits and laboratory services. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its products and services include Irritection, Corrositex, and Lab Services. The company provides its products to various industries such as cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation. The majority of its revenue is generated from the United States and it also exports to other countries.